Introduction: Regulation Becomes a Strategic Force As biotechnology accelerates from gene editing and synthetic biology to AI-driven drug discovery regulation is no longer a background consideration. In 2026, policy frameworks

When a mother in Bengaluru posted a tearful message after her child with an ultra, rare genetic disorder gained access to a customised gene therapy approved via the Food and

Innovation is sprinting ahead. Regulators are scrambling to keep up , and rewrite the playbook on the fly. A Race Against Time Imagine a child born with a rare genetic

When Deadlines Loom: Regulation Shifts You Can’t Ignore in Biotech & Health It was 10:45 pm on a Thursday when Maya raced to her laptop. She had promised her team